JTT-662

· Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-662, covering 2023-01-27 to 2023-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes [Phase 1]

See pricing